Skip to main content
. 2026 Jan 21;14(1):234. doi: 10.3390/biomedicines14010234
DA Dopamine Agonists
PRL Prolactin concentration
ER Estrogen Receptor
PRLR Prolactin Receptor
PRL Prolactin
MRI Magnetic Resonance Imaging
GH Growth Hormone
CT Computed Tomography
aOR Adjusted Odds Ratio
CI Confidence Interval
MEN1 Multiple Endocrine Neoplasia type 1
AIP Aryl hydrocarbon receptor Interacting Protein
NGFR Nerve Growth Factor Receptor